back to top
HomeTagsANGO

ANGO

AngioDynamics (ANGO) reviews web loss for Q2 2025; gross sales drop 8% | AlphaStreet

AngioDynamics Inc. (NASDAQ: ANGO) reported a web loss for the second quarter of 2025 because the medical gadget firm’s revenues decreased 8%. Web loss, excluding...

ANGO Earnings: A snapshot of AngioDynamics’ Q1 2025 outcomes | AlphaStreet

AngioDynamics Inc. (NASDAQ: ANGO) Thursday reported a web loss for the primary quarter of 2025. The medical gadget firm’s revenues decreased by double-digit in...

Most Popular

spot_img